RBC Life Sciences, Inc.
RBC Life Sciences, Inc.
Share · US74926T2015 (OTC)
Overview
No Price
Closing Price OTC 08.12.2025: 0,0002 USD
08.12.2025 21:00
Current Prices from RBC Life Sciences, Inc.
ExchangeTickerCurrencyLast TradePriceDaily Change
OTC: UTC
UTC
RBCL
USD
08.12.2025 21:00
0,0002 USD
0,00 USD
Company Profile for RBC Life Sciences, Inc. Share
RBC Life Sciences, Inc. manufactures, markets, and distributes nutritional supplements and personal care products in North America, Southeast Asia, and Australia. The company's Nutritional Products segment offers nutritional supplements and personal care products, including herbs, vitamins, and minerals; and natural skin, hair, and body care products through a network of independent distributors and license arrangements. Its products include Stem-Kine, a dietary supplement; Microhydrin and Microhydrin Plus antioxidants; VitAloe, a blend of research-backed ingredients; OliViva, an antioxidant beverage to support immune and cardiovascular system; Organic Spirulina, a nutritious alga that provides range of nutrients and easily digested proteins; and NeuroBright to support brain function, and enhance energy and acuity. This segments products also comprise Colo-Vada Plus, a colon cleansing program; HydraCel to enhance the quality of drinking water; 24 Seven, a multivitamin/mineral supplement; Immune 360 to nourish and support the function of the immune system; and Aloe Gelee gel that provides the soothing and moisturizing. Its Medical Products segment offers wound care products for the treatment and healing of wounds, such as pressure ulcers, leg ulcers, cuts, burns, and abrasions. Its products include cleansers, dressings, hydrogels, collagen, calcium alginates, moisture barriers, antimicrobials, and a hydrogel wound dressing with Lidocaine. This segment also offers other wound care products designed to reduce destruction to skin and tissue caused by radiation; and to reduce pain and itching in the skin, and the internal mucosa caused by radiation reactions or reactions to various cancer medications. This segment sells its products under the MPM Medical brand to hospitals, nursing homes, clinics, and pharmacies through a network of medical/surgical supply dealers and pharmaceutical distributors. The company was founded in 1988 and is headquartered in Irving, Texas.
Get up to date insights from finAgent about RBC Life Sciences, Inc.

Company Data

Name RBC Life Sciences, Inc.
Company RBC Life Sciences, Inc.
Website https://www.rbclifesciences.com
Primary Exchange OTC UTC
ISIN US74926T2015
Asset Class Share
Sector Consumer Defensive
Industry Household & Personal Products
CEO David Price
Country United States of America
Currency USD
Employees 0,1 T
Address 2301 Crown Court, 75038 Irving
IPO Date 2000-01-03

Ticker Symbols

Name Symbol
Over The Counter RBCL
More Shares
Investors who hold RBC Life Sciences, Inc. also have the following shares in their portfolio:
Ambitious Plastomac Co. Ltd.
Ambitious Plastomac Co. Ltd. Share
Guangzhou Kingmed Diagnostics Group Co., Ltd.
Guangzhou Kingmed Diagnostics Group Co., Ltd. Share
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025